Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
Journal of Thoracic Disease|April 26, 2019
Diagnostic and clinical features of lung cancer associated with cystic airspacesAnnemie Snoeckx, Pieter Reyntiens, Laurens Carp, et al.
Current Pharmaceutical Biotechnology|May 22, 2014
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancerChristian Rolfo, Daniele Fanale, David S Hong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancerJ G J V Aerts, V Surmont, R J van Klaveren, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Lung Cancer in BelgiumSebahat Ocak, Kurt Tournoy, Thierry Berghmans, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 3, 2019
Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based studyViki Schillemans, France Vrijens, Cindy De Gendt, et al.
Cancer|October 10, 2015
Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its developmentMichael Koller, Sophie Warncke, Marianne J Hjermstad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committeeHarvey I Pass, Dorothy Giroux, Catherine Kennedy, et al.
Oncology|June 5, 2010
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancerV Surmont, J G J V Aerts, R J van Klaveren, et al.
Clinical Lung Cancer|October 16, 2020
Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating MoodMick van de Wiel, Sofie Derijcke, Daniella Galdermans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)Mary E R O'Brien, Rabab M Gaafar, Sanjay Popat, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
Journal of Thoracic Disease|April 26, 2019
Diagnostic and clinical features of lung cancer associated with cystic airspacesAnnemie Snoeckx, Pieter Reyntiens, Laurens Carp, et al.
Current Pharmaceutical Biotechnology|May 22, 2014
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancerChristian Rolfo, Daniele Fanale, David S Hong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancerJ G J V Aerts, V Surmont, R J van Klaveren, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Lung Cancer in BelgiumSebahat Ocak, Kurt Tournoy, Thierry Berghmans, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 3, 2019
Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based studyViki Schillemans, France Vrijens, Cindy De Gendt, et al.
Cancer|October 10, 2015
Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its developmentMichael Koller, Sophie Warncke, Marianne J Hjermstad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committeeHarvey I Pass, Dorothy Giroux, Catherine Kennedy, et al.
Oncology|June 5, 2010
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancerV Surmont, J G J V Aerts, R J van Klaveren, et al.
Clinical Lung Cancer|October 16, 2020
Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating MoodMick van de Wiel, Sofie Derijcke, Daniella Galdermans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)Mary E R O'Brien, Rabab M Gaafar, Sanjay Popat, et al.
Pageof 25